Email Us  
 
 
 
 
   
 

Prior Investments


  Company Overview  
 

@Last Software
GlycoFi
Icovia
M2S
Scribe

GlycoFi, Inc. is revolutionizing how the biopharmaceutical industry produces biotherapeutics. GlycoFi's fungal protein expression platform produces fully humanized glycoproteins of unprecedented homogeneity in a fraction of the time and cost using a chemically defined medium. GlycoFi

GlycoFi was acquired by Merck in June 2006.

www.glycofi.com